vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.
Drug Information

Indication: Short-term treatment & intermittent long-term therapy of mild to moderate of atopic dermatitis in non-immu...

Indication: Hyperpigmentation conditions eg, chloasma (melasma), freckles & lentigines.

Indication: Hyperpigmentation eg, chloasma, freckles & lentigines.

Indication: Moderate to severe atopic dermatitis in patients who are not adequately responsive to or are intolerant of con...

Indication: Short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance,...

Editor's Recommendations
Most Read Articles
17 Jul 2019
While exposure to UV light remains the top risk factor for skin cancer, other variables, such as smoking, immunosuppression and hypertension, also contribute to keratinocyte carcinoma, especially in nonwhite persons, a recent study has found.
Tristan Manalac, 16 Jul 2019
Caffeinated drinks, such as coffee and black tea, may protect against nonmelanoma skin cancer (NMSC) among Chinese in Singapore, according to a recent study.
15 Jan 2019
Alopecia areata (AA) is associated with a variety of comorbid conditions such as metabolic syndrome, iron deficiency anaemia and Helicobacter pylori infections, a recent meta-analysis has shown.